Work

Inhibition of osteoclastogenesis by osteoblast-like cells genetically engineered to produce interleukin-10

Year: 2014

Type: article

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2014.12.040

Authors: Kazuki Fujioka, Tsunao Kishida, Akika Ejima, Kenta Yamamoto, Wataru Fujii, Ken Murakami, Takahiro Seno, Aihiro Yamamoto, Masataka Kohno, Ryo Oda, Toshiro Yamamoto, Hiroyoshi Fujiwara, Yutaka Kawahito, Osam Mazda

Institution: Kyoto Prefectural University of Medicine

Language: English

Topic: Bone Metabolism and Diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, Japan Science and Technology Agency

Awards: Regenerative therapy for metabolic diseases based on chemical direct reprogramming, Application of direct reprogramming technology to periodontal tissue Regenerative therapy, Establishment of a procedure to eliminate viral sequences by means of the chromosome editing, Pathogenesis and regenerative therapy of osteoporosis

OpenAlex ID: W2012244241

FWCI: 0.564

Cites: 29

Cited by: 17

Related to: 10